Home > News > MIV Therapeutics Cited as Leading Technology Innovator
September 19th, 2006
MIV Therapeutics Cited as Leading Technology Innovator
Abstract:
"MIVT continues to gain recognition as a leader in the cardiovascular stent development industry," said Dr. Mark Landy, President of MIVT. "This Frost & Sullivan report is the latest validation for our hydroxyapatite-based nanotechnology and coatings, which we believe will someday be the product of choice for cardiologist around the world."
Source:
businesswire
Bookmark:
| Related News Press |
Nanomedicine
New molecular technology targets tumors and simultaneously silences two ‘undruggable’ cancer genes August 8th, 2025
New imaging approach transforms study of bacterial biofilms August 8th, 2025
Cambridge chemists discover simple way to build bigger molecules – one carbon at a time June 6th, 2025
Electrifying results shed light on graphene foam as a potential material for lab grown cartilage June 6th, 2025
Announcements
Decoding hydrogen‑bond network of electrolyte for cryogenic durable aqueous zinc‑ion batteries January 30th, 2026
COF scaffold membrane with gate‑lane nanostructure for efficient Li+/Mg2+ separation January 30th, 2026
 |
||
 |
||
| The latest news from around the world, FREE | ||
 |
||
|
|
||
| Premium Products | ||
 |
||
|
Only the news you want to read!
Learn More |
||
 |
||
|
Full-service, expert consulting
Learn More |
||
|
|
||